Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: A relevant class-effect

Acta Dermato-Venereologica

Volumn 90, Issue 3, 2010, Pages 311-312

  Garcovich, Simone ^a   Burlando, Martina ^b   Rongioletti, Franco ^b   Garcovich, Antonio ^a   Parodi, Aurora ^b   Amerio, Pierlugi ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; CLOBETASOL PROPIONATE; COLECALCIFEROL; CYCLOSPORIN A; ESCITALOPRAM; ETANERCEPT; INFLIXIMAB; METFORMIN; METHOTREXATE; OLMESARTAN; REPAGLINIDE; ZOFENOPRIL;

ADULT; AGED; CASE REPORT; DERMATITIS; DRUG ERUPTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECZEMA; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LETTER; LICHENOID ERUPTION; MALE; OSTEOPOROSIS; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SKIN DEFECT;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; DRUG ERUPTIONS; ERYTHEMA; HUMANS; IMMUNOGLOBULIN G; LICHENOID ERUPTIONS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953455686     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0839     Document Type: Letter

References (9)

1. Lee H, Song I, Friedrich M, Gauliard A, Detert J, Röwert J, et al. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol 2007; 156: 486-491.
2. Sontheimer RD. Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives. J Invest Dermatol 2009; 129: 1088-1099.
3. Asarch A, Gottlieb AB, Lee J, Masterpol KS, Scheinman PL, Stadecker MJ, et al. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol 2009; 61: 104-111.
4. Garcovich S, Manco S, Zampetti A, Amerio P, Garcovich A. Onset of lichen planopilaris during treatment with etanercept. Br J Dermatol 2008; 158: 1161-1163.
5. Vergara G, Silvestre JF, Betlloch I, Vela P, Albares MP, Pascual JC. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002; 138: 1258-1259.
6. De Simone C, Caldarola G, D'Agostino M, Rotoli M, Capizzi R, Amerio P. Lichenoid reaction induced by adalimumab. J Eur Acad Dermatol Venereol 2008; 22: 626-627.
7. Seneschal J, Lepreux S, Bouyssou-Gauthier M, Héliot-Hosten I, Economu A, Dehais J, et al. Psoriasiform drug eruptions under anti-TNF treatment of arthritis are not true psoriasis. Acta Derm Venereol 2007; 87: 77-80.
8. Meller S, Gilliet M, Homey B. Chemokines in the pathogenesis of lichenoid tissue reactions. J Invest Dermatol 2009; 129: 315-319.
9. Flendrie M, Vissers WHPM, Creemers MCW, de Jong EMGJ, van de Kerkhof PCM, van Riel PLCM. Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther 2005; 7: R666-676.